Vassiliki Karantza Selected Research

Vassiliki Karantza Research Topics

Disease

23	Neoplasms (Cancer) 11/2023 - 01/2010
14	Triple Negative Breast Neoplasms 05/2024 - 01/2010
8	Breast Neoplasms (Breast Cancer) 10/2021 - 06/2010
5	Carcinogenesis 07/2015 - 07/2008
3	Pathologic Complete Response 11/2023 - 01/2020
2	Disease Progression 01/2023 - 01/2020
2	Inflammation (Inflammations) 04/2013 - 06/2010
1	Carcinoma in Situ 11/2023
1	Pancytopenia 01/2021
1	Sepsis (Septicemia) 01/2021
1	Shock 01/2021
1	Neutropenia 01/2021
1	Stomach Neoplasms (Stomach Cancer) 01/2016
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2016
1	Melanoma (Melanoma, Malignant) 05/2015
1	Critical Illness (Critically Ill) 03/2014
1	Rectal Neoplasms (Rectal Cancer) 03/2014
1	Colorectal Neoplasms (Colorectal Cancer) 03/2014
1	Lymphoma (Lymphomas) 01/2012
1	Hyperplasia 01/2012
1	Prostatic Neoplasms (Prostate Cancer) 01/2012
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2011
1	Starvation 03/2011

Drug/Important Bio-Agent (IBA)

12	pembrolizumabIBA 05/2024 - 01/2016
6	Paclitaxel (Taxol)FDA LinkGeneric 10/2022 - 08/2011
5	Carboplatin (JM8)FDA LinkGeneric 10/2022 - 10/2014
4	Proteins (Proteins, Gene)FDA Link 10/2014 - 06/2010
3	B7-H1 AntigenIBA 05/2024 - 01/2021
3	Gemcitabine FDA Link 01/2022 - 02/2012
2	Biomarkers (Surrogate Marker)IBA 05/2024 - 01/2023
2	LigandsIBA 11/2023 - 01/2018
2	Messenger RNA (mRNA)IBA 01/2023 - 04/2014
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2022 - 01/2020
2	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2022 - 01/2020
2	Epirubicin (Ellence)FDA LinkGeneric 10/2022 - 01/2020
2	Estrogen ReceptorsIBA 10/2021 - 01/2018
2	taxaneIBA 01/2021 - 08/2011
2	human ERBB2 proteinIBA 01/2021 - 07/2015
2	Beclin-1IBA 01/2012 - 06/2010
1	Hematoxylin (Haematoxylon)IBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Peptides (Polypeptides)IBA 01/2023
1	ApolipoproteinsIBA 01/2023
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2023
1	Albumin-Bound Paclitaxel FDA Link 01/2022
1	AnthracyclinesIBA 01/2021
1	olaparibIBA 01/2021
1	Poly Adenosine Diphosphate RiboseIBA 01/2021
1	eribulin FDA Link 01/2021
1	130-nm albumin-bound paclitaxelIBA 12/2020
1	ErbB Receptors (EGF Receptor)IBA 01/2018
1	Monoclonal AntibodiesIBA 01/2018
1	Dihydrotachysterol (AT 10)IBA 01/2016
1	Amino Acids FDA Link 07/2015
1	Riluzole FDA LinkGeneric 05/2015
1	Glutamic Acid (Glutamate)FDA Link 05/2015
1	metabotropic glutamate receptor type 1IBA 05/2015
1	navitoclaxIBA 10/2014
1	Trastuzumab (Herceptin)FDA Link 04/2014
1	Chloroquine (Aralen)FDA LinkGeneric 03/2014
1	Fluorouracil (Carac)FDA LinkGeneric 03/2014
1	Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)IBA 01/2014
1	Oxygen (Dioxygen)IBA 06/2012
1	Docetaxel (Taxotere)FDA Link 02/2012
1	Imatinib Mesylate (Gleevec)FDA Link 02/2012
1	Proteasome InhibitorsIBA 08/2011
1	Mitogen-Activated Protein KinasesIBA 08/2011
1	Bortezomib (Velcade)FDA Link 08/2011
1	Bcl-2-Like Protein 11IBA 08/2011
1	Tricarboxylic AcidsIBA 03/2011
1	Keratins (Keratin)IBA 06/2010
1	Keratin-8 (Keratin 8)IBA 06/2010
1	Estrogens (Estrogen)FDA Link 01/2010
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2010

Therapy/Procedure

11	Drug Therapy (Chemotherapy) 05/2024 - 06/2012
10	Therapeutics 11/2023 - 07/2008
6	Neoadjuvant Therapy 11/2023 - 01/2020
2	Immunotherapy 01/2021 - 01/2016
1	Adjuvant Chemotherapy 01/2021
1	Critical Care (Surgical Intensive Care) 03/2014
1	Radiotherapy 03/2014